logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10617688 B1

PDFFull Text
Date of Patent:
Apr. 14, 2020

Filed:

Mar. 22, 2017

Use of pharmaceutical composition for the treatment of skin erythema in poikilodermas

Applicant:

Doris Maria Hexsel, Porto Alegre, BR;

Inventor:

Doris Maria Hexsel, Porto Alegre, BR;

Assignee:

Other;

Attorneys:

Lambert Shortell & Connaughton

Gary E. Lambert

David J. Connaughton, Jr.

Primary Examiner:

Dennis Heyer

Int. Cl.
CPC ...
A61K 31/498 (2006.01); A61K 31/4174 (2006.01); A61K 31/4168 (2006.01); A61K 31/433 (2006.01); A61K 31/4458 (2006.01); A61K 31/137 (2006.01); A61K 31/155 (2006.01); A61K 31/198 (2006.01); A61P 17/00 (2006.01); A61K 31/421 (2006.01); A61K 31/165 (2006.01); A61K 31/4164 (2006.01); A61K 31/506 (2006.01); A61K 31/13 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/498 (2013.01); A61K 31/13 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/198 (2013.01); A61K 31/4164 (2013.01); A61K 31/4168 (2013.01); A61K 31/4174 (2013.01); A61K 31/421 (2013.01); A61K 31/433 (2013.01); A61K 31/4458 (2013.01); A61K 31/506 (2013.01); A61P 17/00 (2018.01); A61K 9/0014 (2013.01);
Abstract

The present invention pertains to the technological sector of the pharmaceutical industry and, more specifically, refers to a second use composition intended for the treatment of a dermatology condition called Poikiloderma of Civatte. The solution proposed in this document is the use of a topical composition containing any substance alone or in combination from the pharmacological group of alpha-adrenergic receptor agonists in therapeutic quantities to treat color of the lesions of Poikiloderma of Civatte. The application of this composition for the condition of Poikiloderma of Civatte results in significant improvement of the color of the skin lesions, also improving the vascular component present in this condition and can be associated with other compounds.

Find Patent Forward Citations

Loading…